stars 1 stars 2 stars 3

Visano Theranostics is transforming the landscape of medical imaging and therapy with our innovative nanobubble technology, designed to outperform traditional ultrasound contrast agents. Our nanobubbles last up to 20 times longer than microbubbles, providing extended imaging windows and enhanced diagnostic precision. Their nanoscale size allows for superior tissue penetration and the ability to target both vascular and extravascular biomarkers, unlocking applications beyond the reach of conventional agents. With a high yield production process and tunable properties, our platform supports a broad range of clinical uses, from foundational imaging to targeted diagnostics and ultrasound-mediated theranostics. This versatility positions Visano as a leader in advancing cost-effective, real-time ultrasound solutions that improve patient outcomes, reduce healthcare costs, and expand access to cutting-edge theranostics globally.

Website https://www.visanotheranostics.com
Employees 1 (1 on RocketReach)
Founded 2024
Industry Biotechnology Research

Visano Theranostics Questions

Michael Haag is the Chief Executive Officer and Founder of Visano Theranostics.

1 people are employed at Visano Theranostics.

Top Visano Theranostics Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users